Mizuno, Junichi
Urabe, Yuji
Oka, Shiro
Konishi, Hirona
Ishibashi, Kazuki
Fukuhara, Motomitsu
Tanaka, Hidenori
Tsuboi, Akiyoshi
Yamashita, Ken
Hiyama, Yuichi
Kotachi, Takahiro
Takigawa, Hidehiko
Yuge, Ryo
Hiyama, Toru
Tanaka, Shinji
Article History
Received: 2 August 2023
Accepted: 15 January 2024
First Online: 20 January 2024
Declarations
:
: This study was reviewed and approved by the Institutional Review Board of Hiroshima University Hospital, approval number E2022-0079.Informed consent for cancer treatment was offered and accepted by all patients, and written informed consent was obtained from all patients for participation in this study.
: Not applicable.
: The authors declare no competing interests.